NCT00901225 · OUTCOME

Number of Subjects Experiencing Graft Failure

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant · Source last updated 2014-05-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: 12 months

What was measured

To investigate the hematological activity of Plerixafor as measured by Graft Failure. Graft failure is defined as failure of initial engraftment (primary graft failure) or initial engraftment, but subsequent loss of hematopoiesis (secondary graft failure).

Groups in this outcome

G-CSF Plus Plerixafor

Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
G-CSF Plus Plerixafor	20

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
G-CSF Plus Plerixafor	0	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0

denoms

counts
group Id
OG000
value
20
units
Participants

description

groups

description
Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.
id
OG000
title
G-CSF Plus Plerixafor

param Type

NUMBER

reporting Status

POSTED

time Frame

12 months

title

Number of Subjects Experiencing Graft Failure

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice